Raritan Pharmaceuticals

Raritan Pharmaceuticals operates as a specialized contract manufacturer and developer in the consumer healthcare space, with expertise in tablets, capsules, liquids, creams, and film-delivery systems. The company targets the OTC, medical device, and therapeutic cosmetics markets, emphasizing speed-to-market, quality, and kosher certification for many products. While presenting itself with broad sector claims, its core business appears to be contract services and generic OTC product manufacturing rather than novel therapeutic discovery. Key strategic focuses include taste-masked formulations and first-to-market generic OTC launches.

Formulation and manufacturing expertise across multiple dosage forms including chewable/fast-dissolving tablets, powders, capsules, liquids, creams, and film-delivery systems, with specific competencies in taste-masking and kosher-certified production.

Raritan competes in a fragmented but competitive landscape against large, global CDMOs (e.g., Catalent, Lonza) and established generic OTC manufacturers (e.g., Perrigo, private label producers). Its differentiation relies on agility, specialized formulations, and niche certifications rather than scale.